For that reason, any decision to pause or stop GLP-1 therapy should always be made in consultation with a qualified healthcare provider who can document the plan, adjust dosing, and help protect continued coverage
Individuals on retatrutide, particularly for weight management, need to be aware of potential side effects, how to identify them, and when to reach out to their healthcare teams
By disentangling dietary risk factors, we identified the portion of IHD burden directly modifiable through food interventions
Multiple injections or long-term use
However, generally excreted does not mean entirely without consequence. Emerging research has raised questions about whether chronically elevated serum B12 levels may serve as a marker for underlying conditions or could be associated with certain health concerns
Gastroenterology 158 , 19131928 (2020)